Adjuvant nodal field radiation in resected Stage III melanoma: A single ‐centre retrospective study in Christchurch, New Zealand
ConclusionPatients treated with adjuvant radiation remain at moderate risk of regional and high risk of distant relapse, despite the use of modern radiation techniques. Adjuvant radiation was associated with improved local control but infield recurrence rates remained a problem. The role of combined adjuvant radiation and immunotherapy in improving these outcomes requires further investigation.
Source: Journal of Medical Imaging and Radiation Oncology - Category: Radiology Authors: Tian Weng Leong,
George McCook,
Christopher MA Frampton,
Bridget A Robinson,
Melissa L James Tags: Radiation Oncology —Original Article Source Type: research
More News: Cancer & Oncology | Immunotherapy | Melanoma | New Zealand Health | Radiology | Skin Cancer | Study